- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
7 result(s) found for: Receiver Operating Characteristic.
Displaying page 1 of 1.
EudraCT Number: 2013-001592-20 | Sponsor Protocol Number: 91710346.2.1 | Start Date*: 2013-07-25 |
Sponsor Name: | ||
Full Title: Pilot study for studying the influence of low-dose propofol on the classification of movements from the electroencephalogram in healthy participants | ||
Medical condition: Intraoperative awareness during general anesthesia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003788-13 | Sponsor Protocol Number: 1013 | Start Date*: 2023-09-21 |
Sponsor Name:Heikki Minn | ||
Full Title: Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? | ||
Medical condition: Metastatic prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: FI (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005304-14 | Sponsor Protocol Number: AL0205PR | Start Date*: 2007-01-09 | |||||||||||
Sponsor Name:Allergopharma Joachim Ganzer KG | |||||||||||||
Full Title: Design of optimally-diagnostic skin test solutions for diagnosis of sensitisation to a 6-grass pollen mixture, house dust mite (Dermatophagoides pteronyssinus), birch pollen and mugwort pollen and ... | |||||||||||||
Medical condition: Sensitisation to one or more allergens of 6-grass pollen mixture (Holcus lanatus, Dactylis glomerata, Lolium perenne, Phleum pratense, Poa pratensis, Festuca elatior), house dust mite (Dermatophago... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003981-42 | Sponsor Protocol Number: 2012.2708 | Start Date*: 2014-10-20 |
Sponsor Name:University Medical Center Groningen [...] | ||
Full Title: Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | ||
Medical condition: Estrogen receptor positive metastatic breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003007-29 | Sponsor Protocol Number: 2014-0087054 | Start Date*: 2015-08-12 |
Sponsor Name:University Hospitals Leuven, department of pediatrics | ||
Full Title: The Polysaccharide Antibody Response Study: Typhim Vi response and allohemagglutinins versus Pneumo 23 vaccine response in the diagnosis of Specific Polysaccharide Antibody Deficiency. | ||
Medical condition: Specific polysaccharide antibody deficiency. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000716-30 | Sponsor Protocol Number: RGL-003-001 | Start Date*: 2020-09-10 | |||||||||||
Sponsor Name:Gedeon Richter Plc. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, proof-of-concept study to evaluate a combined oral contraceptive (COC) containing 30 µg ethinylestradiol and 150 µg levonorgestrel plus ... | |||||||||||||
Medical condition: Hypoactive sexual desire disorder (HSDD) secondary to combined oral contraception use. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) PL (Completed) CZ (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005610-33 | Sponsor Protocol Number: IAB-CD8-203 | Start Date*: 2022-02-09 | |||||||||||
Sponsor Name:ImaginAb, Inc. | |||||||||||||
Full Title: iPREDICT Trial: A Phase IIB, Open Label, Study of 89Zr-Df-Crefmirlimab PET/CT in Subjects with Selected Advanced or Metastatic Malignancies including Melanoma, Merkel Cell, Renal Cell and Non-Small... | |||||||||||||
Medical condition: To predict if patients with selected advanced or metastatic malignancies including Melanoma, Merkel Cell, Renal Cell and Non-Small Cell Lung Cancers, will respond to standard-of-care Immunotherapy ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.